Mesothelioma shows promising response to existing immunotherapy drug By Lizzy on December 6, 2018 Malignant pleural mesothelioma shows a promising response to treatment with the antibody drug pembrolizumab, which is used to treat other cancers. Source: MedicalNewsToday.com Published in Health News Lizzy More from Health NewsMore posts in Health News »Researcher Studies How Messaging On COVID-19 Disparities Affects Policy PreferencesHalf of U.S. adults have received at least one Covid shot in milestone for vaccination campaignUK scientists launch human challenge trial to study Covid reinfectionCOVID Deaths Higher With Neuro Syndromes in Hospitalized PatientsCOVID Deaths Higher With Neuro Syndromes in Hospitalized Patients‘That’s Not Spin, That’s Stats’: What We Heard This Week‘That’s Not Spin, That’s Stats’: What We Heard This Week